BRPI0916895A2 - uso de lisina, arginina e outros compostos aminados, produto e administração de dosagem de produto - Google Patents
uso de lisina, arginina e outros compostos aminados, produto e administração de dosagem de produtoInfo
- Publication number
- BRPI0916895A2 BRPI0916895A2 BRPI0916895A BRPI0916895A BRPI0916895A2 BR PI0916895 A2 BRPI0916895 A2 BR PI0916895A2 BR PI0916895 A BRPI0916895 A BR PI0916895A BR PI0916895 A BRPI0916895 A BR PI0916895A BR PI0916895 A2 BRPI0916895 A2 BR PI0916895A2
- Authority
- BR
- Brazil
- Prior art keywords
- product
- arginine
- lysine
- amino compounds
- dosage administration
- Prior art date
Links
- 239000004475 Arginine Substances 0.000 title 1
- 239000004472 Lysine Substances 0.000 title 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 title 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 title 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KE78208 | 2008-08-04 | ||
| PCT/KE2009/000019 WO2010016628A1 (en) | 2008-08-04 | 2009-07-10 | Conjugated suramin amino compounds for medical conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0916895A2 true BRPI0916895A2 (pt) | 2016-02-10 |
Family
ID=41663832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0916895A BRPI0916895A2 (pt) | 2008-08-04 | 2009-07-10 | uso de lisina, arginina e outros compostos aminados, produto e administração de dosagem de produto |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110217364A1 (pt) |
| EP (1) | EP2326319A4 (pt) |
| CN (1) | CN102112123A (pt) |
| AP (1) | AP2011005556A0 (pt) |
| AU (1) | AU2009280253A1 (pt) |
| BR (1) | BRPI0916895A2 (pt) |
| CA (1) | CA2733228A1 (pt) |
| GB (1) | GB2474809B (pt) |
| HK (1) | HK1154202A1 (pt) |
| WO (1) | WO2010016628A1 (pt) |
| ZA (1) | ZA201101670B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180078515A1 (en) * | 2015-03-20 | 2018-03-22 | Sammy Oyoo OPIYO | Use of suramin and arginase inhibitors in malignant neoplasia |
| CN108078971A (zh) * | 2017-11-28 | 2018-05-29 | 南方医科大学 | Suramin在制备SEVI形成抑制剂中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4120891A (en) * | 1977-07-01 | 1978-10-17 | American Cyanamid Company | Ureylene naphthalene sulfonic acids |
| US5576351A (en) * | 1989-12-29 | 1996-11-19 | Mcgaw, Inc. | Use of arginine as an immunostimulator |
| US5173509A (en) * | 1990-03-29 | 1992-12-22 | The United States Of America As Represented By The Department Of Health And Human Services | Suramin and active analogues thereof in the treatment of hypercalcemia |
| GB9024738D0 (en) * | 1990-11-14 | 1991-01-02 | Erba Carlo Spa | A new method of treatment of tumor necroisis factor(tnf)-related diseases |
| EP0664700A1 (en) * | 1992-10-13 | 1995-08-02 | Otsuka America Pharmaceutical, Inc. | Treatment of cachexia and inhibition of il-6 activity |
| US5945452A (en) * | 1993-06-11 | 1999-08-31 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity |
| WO1999043311A2 (en) * | 1998-02-26 | 1999-09-02 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Conjugated suramin or derivatives thereof with peg, polyaspartate or polyglutamate for cancer treatment |
| US20050148669A1 (en) * | 2004-10-21 | 2005-07-07 | Daniel Amato | Amino acid esters as nutrient supplements and methods of use |
| CA2717788A1 (en) * | 2007-07-09 | 2009-01-15 | Eastern Virginia Medical School | Substituted nucleoside derivatives with antiviral and antimicrobial properties |
-
2009
- 2009-07-10 CA CA2733228A patent/CA2733228A1/en not_active Abandoned
- 2009-07-10 BR BRPI0916895A patent/BRPI0916895A2/pt not_active IP Right Cessation
- 2009-07-10 EP EP09805104A patent/EP2326319A4/en not_active Withdrawn
- 2009-07-10 AP AP2011005556A patent/AP2011005556A0/xx unknown
- 2009-07-10 AU AU2009280253A patent/AU2009280253A1/en not_active Abandoned
- 2009-07-10 CN CN200980130804.0A patent/CN102112123A/zh active Pending
- 2009-07-10 GB GB1103634.0A patent/GB2474809B/en not_active Expired - Fee Related
- 2009-07-10 WO PCT/KE2009/000019 patent/WO2010016628A1/en active Application Filing
- 2009-07-10 US US13/057,643 patent/US20110217364A1/en not_active Abandoned
-
2011
- 2011-03-03 ZA ZA2011/01670A patent/ZA201101670B/en unknown
- 2011-08-02 HK HK11108016.0A patent/HK1154202A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201101670B (en) | 2012-08-29 |
| US20110217364A1 (en) | 2011-09-08 |
| EP2326319A1 (en) | 2011-06-01 |
| GB201103634D0 (pt) | 2011-04-13 |
| CN102112123A (zh) | 2011-06-29 |
| EP2326319A4 (en) | 2011-12-21 |
| AU2009280253A1 (en) | 2010-02-11 |
| WO2010016628A1 (en) | 2010-02-11 |
| GB2474809B (en) | 2013-03-13 |
| AP2011005556A0 (en) | 2011-02-28 |
| CA2733228A1 (en) | 2010-02-11 |
| GB2474809A (en) | 2011-04-27 |
| HK1154202A1 (en) | 2012-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0917315A2 (pt) | anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica | |
| SMT201600258B (it) | Composto indolico e suo uso farmaceutico | |
| BRPI0918502A2 (pt) | aminoindanos substituídos e análogos dos mesmos, e o uso farmacêutico dos mesmos | |
| BRPI0821115A2 (pt) | Composto derivado de aminotriazol, medicamento, composição farmacêutica e uso do composto | |
| BR112013023174A2 (pt) | "compostos derivados de triterpenoide de c4-monometila, composição farmacêutica compreendendo os referidos compostos e uso dos mesmos" | |
| BRPI0915137A2 (pt) | uso de pelo menos um composto, peptídeo, e, formulação farmacêutica | |
| BR112013016772A2 (pt) | composto, uso do composto, composição farmacêutica, oligonucleotídeo e conjugado | |
| BR112013008259A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0915136A2 (pt) | uso de pelo menos um composto, peptídeo, e, formulação farmacêutica | |
| BR112013011448A2 (pt) | composto, composição farnmacêutica, e, uso do composto | |
| BR112013015397A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0909028A2 (pt) | nitroimidazóis bicíclicos covalentemente ligados a fenil oxazolidinonas substituídas, composições farmacêuticas e uso dos mesmos | |
| BRPI0913726A2 (pt) | rapalogs, composições farmacêuticas, métodos de preparo e uso dos mesmos | |
| BRPI0912717A2 (pt) | Composição farmacêutica, e, uso de 5-azacitidina | |
| BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
| BRPI0908097A2 (pt) | uso de pelo menos um composto, peptídeo, e, formulação farmacêutica. | |
| BR112012004335A2 (pt) | composto, composição farmacêutica, e, uso do composto. | |
| BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
| BRPI1009392A2 (pt) | "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica." | |
| BR112012003800A2 (pt) | composição, peptídeo, e formulação farmacêutica. | |
| CL2014000849A1 (es) | Compuestos derivados de benzilindazoles sustituido, inhibidores de la quinasa bub1; procedimiento de fabricacion; composicion farmaceutica; combinacion farmaceutica; y su uso en el tratamiento de enfermedades hiperproliferativas. | |
| BRPI1008039A2 (pt) | composto, mistura, composição farmacêutica, e, uso de um coposto, de uma mistura ou de uma composição farmacêutica | |
| BRPI0920355A2 (pt) | composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |